Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Comoros Technology Digest.
Press releases published on June 10, 2025
Quest PharmaTech Announces Opposition to OQPBIOM's Acquisition of AdBioTech
GlobeNewswire
·
June 10, 2025
EDMONTON, Alberta, June 10, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary …
argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s Disease
GlobeNewswire
·
June 10, 2025
ALKIVIA data demonstrate significant improvement in muscle strength and physical function in myositis patients treated with efgartigimod RHO data show efgartigimod achieved sustained reduction in autoantibodies and improved functional outcomes in patients …
Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus…
GlobeNewswire
·
June 10, 2025
Consideration composed of a $350m up-front payment and up to $1.0bn in development, regulatory and commercial milestones, along with mid-single to low double-digit royalties on Global Net Sales OTELFINGEN, Switzerland, June 10, 2025 (GLOBE NEWSWIRE) -- …
BioAegis Therapeutics Announces US Navy Contract to Support Phase 2 Study of Recombinant Human Gelsolin, for Inflammasome-Driven Decompression Sickness (DCS)
GlobeNewswire
·
June 10, 2025
NORTH BRUNSWICK, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, a pioneering biotech company at the forefront of innovative therapies for acute and chronic inflammatory diseases, announces that it will conduct a Phase 2 study of rhu-pGSN …
Xilio Therapeutics Appoints Akintunde Bello, Ph.D., to its Board of Directors
GlobeNewswire
·
June 10, 2025
WALTHAM, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced the …
Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 10, 2025
SAN DIEGO, June 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 74 …
Vimeo Elects Adam Cahan, Lydia Jett, and Kirsten Kliphouse to Board of Directors
GlobeNewswire
·
June 10, 2025
NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Vimeo, Inc. (NASDAQ: VMEO), one of the largest and most trusted private video networks in the world, today announced the election of Adam Cahan, Lydia Jett, and Kirsten Kliphouse to its Board of Directors. The …
Voting Rights and Shares Capital of the Company
GlobeNewswire
·
June 10, 2025
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, June 10, 2025 (GLOBE NEWSWIRE) -- Market: Euronext Paris / Nasdaq …
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
GlobeNewswire
·
June 10, 2025
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 10 juin 2025 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / Nasdaq Euronext Compartiment : B Code ISIN : …
Celularity Announces Chief Financial Officer Transition
GlobeNewswire
·
June 10, 2025
FLORHAM PARK, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, today announced that it terminated the employment of its Chief Financial Officer (“CFO”), …
HP Inc. Declares Dividend
GlobeNewswire
·
June 10, 2025
PALO ALTO, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- HP Inc. (NYSE: HPQ) has declared a cash dividend of $0.2894 per share on the company’s common stock. The dividend, the fourth in HP’s fiscal year 2025, is payable on October 1, 2025, to stockholders of …
Quick Custom Intelligence Continues Rapid Growth in the Australian Market in Partnership with Gaming Dynamics
GlobeNewswire
·
June 10, 2025
SAN DIEGO, June 10, 2025 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI), a global leader in operational intelligence software for the gaming and hospitality industries, is pleased to announce continued expansion across Australia in collaboration with …
Tilray Brands' Stockholders Approve Reverse Stock Split; Company Pauses Implementation as It Evaluates Timing and Stock Price
GlobeNewswire
·
June 10, 2025
NEW YORK and LEAMINGTON, Ontario, June 10, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness …
New Spherix Global Insights Data Reveals 85% of FSGS Patients Have Actively Progressing Disease Despite Treatment, Underscoring Urgent Demand for Innovative Treatments
GlobeNewswire
·
June 10, 2025
EXTON, PA, June 10, 2025 (GLOBE NEWSWIRE) -- Patients battling focal segmental glomerulosclerosis (FSGS) often face a discouraging path, marked by continued disease progression and limited therapeutic options. For nephrologists, this rare kidney disease is …
Inventiva Announces the Appointment of Renée Aguiar-Lucander to its Board of Directors
GlobeNewswire
·
June 10, 2025
Daix (France), New York City (New York, United States), June 10, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of …
Ontra Announces $70M in Financing to Accelerate Growth
GlobeNewswire
·
June 10, 2025
SAN FRANCISCO, June 10, 2025 (GLOBE NEWSWIRE) -- Ontra, the global leader in AI legal technology for private markets, today announced that it has successfully closed a $70 million financing round with Silicon Valley Bank (SVB), a division of First Citizens …
XPro™ Reduces Amyloid and Enhances Behavior Post Traumatic Brain Injury in an Animal Model of Alzheimer’s Disease: Supported by Department of Defense
GlobeNewswire
·
June 10, 2025
XPro™ Treatment Post-TBI Prevents Short- and Long-Term Alzheimer’s-like Pathology in transgenic mice Boca Raton, Florida, June 10, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology …
XRP News: Vaultro Finance Successfully Raised 13,000 XRP, Surpassing 15% of Its Presale Allocation — Join $VLT Presale
GlobeNewswire
·
June 10, 2025
SINGAPORE, June 10, 2025 (GLOBE NEWSWIRE) -- Vaultro Finance has reached a significant milestone in its startup journey by raising 13,000 XRP in its ongoing $VLT Presale Round, moving past 15% of its targeted presale allocation. This achievement comes less …
Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development
GlobeNewswire
·
June 10, 2025
NEW HAVEN, Conn., June 10, 2025 (GLOBE NEWSWIRE) -- Bexorg, Inc., a pioneering techbio company working to decode the human brain and advance new therapies for central nervous system (CNS) disorders, today announced a multi-program research collaboration …
8th Wall disrupts the legacy game engine model with the official launch of AI-native 3D development platform
GlobeNewswire
·
June 10, 2025
PALO ALTO, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Today, 8th Wall announced the general release of 8th Wall Studio, a 3D game engine purpose-built for the AI era. Designed from the ground up for modern development, 8th Wall eliminates the bloat and …